The State Medical Board of Ohio issues the following statement regarding the use of chelation therapy by licensed physicians:

l) Chelation therapy has been approved by the Food and Drug Administration (hereinafter "F.D.A.") for a limited number of indications, one of which is for the treatment of heavy metal poisoning.

2) Chelation therapy has not been approved by the F.D.A. for such indications as cancer or arteriosclerosis.

3) Since the F.D.A. has not approved chelation therapy for some indications, a physician who uses chelation therapy for unapproved uses could be in violation of Sections 4731.22(B)(2), (3) and (6), Ohio Revised Code, as well as any applicable F.D. A. regulations.

4) As set forth in Title 21, Code of Federal Regulations, Section 312, which is attached, an Ohio physician can use chelation therapy for an unapproved use for investigational or research work. To obtain clearance for investigational or research work, please contact the following section of the F.D.A.:

Document and Records Service Section (HFN-106)
Bureau of Drugs and Biologics
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland 20857
 

approved 8/84